Molly A. Silvers

625 total citations
7 papers, 391 citations indexed

About

Molly A. Silvers is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, Molly A. Silvers has authored 7 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Toxicology. Recurrent topics in Molly A. Silvers's work include Bioactive Compounds and Antitumor Agents (4 papers), Cancer therapeutics and mechanisms (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Molly A. Silvers is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Cancer therapeutics and mechanisms (2 papers) and Genomics, phytochemicals, and oxidative stress (2 papers). Molly A. Silvers collaborates with scholars based in United States, India and Brazil. Molly A. Silvers's co-authors include David A. Boothman, Sandra Feuer DiTusa, Robert W. Wallace, Aaron P. Smith, Ralph J. DeBerardinis, Xiuquan Luo, Matthew E. Merritt, Carol M. Taylor, Grover L. Waldrop and Muhammad Shaalan Beg and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Scientific Reports.

In The Last Decade

Molly A. Silvers

7 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Molly A. Silvers United States 7 151 144 144 90 82 7 391
Ganglin Yan China 14 211 1.4× 105 0.7× 262 1.8× 10 0.1× 35 0.4× 34 547
Papiya Majumdar India 9 37 0.2× 78 0.5× 323 2.2× 84 0.9× 17 0.2× 11 450
Yousheng Hua United States 11 49 0.3× 39 0.3× 216 1.5× 86 1.0× 16 0.2× 14 362
Minghua Gu United States 9 24 0.2× 94 0.7× 118 0.8× 17 0.2× 21 0.3× 12 312
Danuša Vlasáková Slovakia 10 35 0.2× 36 0.3× 149 1.0× 13 0.1× 36 0.4× 16 328
M. Badr Egypt 14 43 0.3× 622 4.3× 214 1.5× 17 0.2× 55 0.7× 32 864
Katarzyna Skupińska Poland 10 31 0.2× 88 0.6× 209 1.5× 3 0.0× 45 0.5× 13 389
Dominika Radomska Poland 10 80 0.5× 160 1.1× 100 0.7× 4 0.0× 26 0.3× 19 481
Lindon W. K. Moodie Sweden 13 12 0.1× 147 1.0× 144 1.0× 28 0.3× 22 0.3× 26 466
Nuran Diril Türkiye 11 32 0.2× 299 2.1× 109 0.8× 9 0.1× 12 0.1× 19 400

Countries citing papers authored by Molly A. Silvers

Since Specialization
Citations

This map shows the geographic impact of Molly A. Silvers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molly A. Silvers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molly A. Silvers more than expected).

Fields of papers citing papers by Molly A. Silvers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molly A. Silvers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molly A. Silvers. The network helps show where Molly A. Silvers may publish in the future.

Co-authorship network of co-authors of Molly A. Silvers

This figure shows the co-authorship network connecting the top 25 collaborators of Molly A. Silvers. A scholar is included among the top collaborators of Molly A. Silvers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molly A. Silvers. Molly A. Silvers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Silvers, Molly A., Stanisław Deja, Robert A. Egnatchik, et al.. (2017). The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism. Journal of Biological Chemistry. 292(44). 18203–18216. 76 indexed citations
2.
Beg, Muhammad Shaalan, Xiumei Huang, Molly A. Silvers, et al.. (2017). Using a novel NQO1 bioactivatable drug, beta‐lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer. Journal of Surgical Oncology. 116(1). 83–88. 28 indexed citations
3.
Silvers, Molly A., Guilherme A. M. Jardim, Jarbas M. Resende, et al.. (2016). Synthesis and antitumor activity of selenium-containing quinone-based triazoles possessing two redox centres, and their mechanistic insights. European Journal of Medicinal Chemistry. 122. 1–16. 73 indexed citations
4.
Silvers, Molly A., Svetlana Pakhomova, David B. Neau, et al.. (2016). Crystal Structure of Carboxyltransferase from Staphylococcus aureus Bound to the Antibacterial Agent Moiramide B. Biochemistry. 55(33). 4666–4674. 15 indexed citations
5.
Chakrabarti, Gaurab, Molly A. Silvers, Mariya Ilcheva, et al.. (2015). Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. Scientific Reports. 5(1). 17066–17066. 49 indexed citations
6.
7.
Silvers, Molly A., Gregory T. Robertson, Carol M. Taylor, & Grover L. Waldrop. (2014). Design, Synthesis, and Antibacterial Properties of Dual-Ligand Inhibitors of Acetyl-CoA Carboxylase. Journal of Medicinal Chemistry. 57(21). 8947–8959. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ganglin Yan Breakdown of academic impact, for papers by Papiya Majumdar Breakdown of academic impact, for papers by Yousheng Hua Breakdown of academic impact, for papers by Minghua Gu Breakdown of academic impact, for papers by Danuša Vlasáková Breakdown of academic impact, for papers by M. Badr Breakdown of academic impact, for papers by Katarzyna Skupińska Breakdown of academic impact, for papers by Dominika Radomska Breakdown of academic impact, for papers by Lindon W. K. Moodie Breakdown of academic impact, for papers by Nuran Diril
Rankless by CCL
2026